Synairgen Share Discussion Threads

[pdt] 17/4/2020 16:17

This is encouraging;

"An experimental trial of recombinant human interferon alpha nasal drops to prevent coronavirus disease 2019 in medical staff in an epidemic area"



Conclusion In this investigator-initiated open-label study, we observed that rhIFN-α nasal drops can effectively prevent COVID-19 in treated medical personnel. Our results also indicate that rhIFN-α nasal drops have potential promise for protecting susceptible healthy people during the coronavirus pandemic.

[jev1] 17/4/2020 16:15

No, it was far higher at 360p

_______

The successful completion of the Phase II study (SG016) would imply a rNPV of as much as c.£475m or a c.360p target price suggesting a c.£360m (240p) uplift on the current estimated NPV.

[wetdream] 17/4/2020 16:04

I think that was if the Pilot phase was successful.

[bobaxe1] 17/4/2020 15:55

finnCap said 120

[imjustdandy] 17/4/2020 15:55

RSP moving - big finish and news next week - thank you

[likya123] 17/4/2020 15:51

Last 40 mins and expecting a rise into close...

[talk2dubya] 17/4/2020 15:46

Can sell 25k at 59.5p. Bid rising and can get a quote.

[imjustdandy] 17/4/2020 15:42

This update was 3 weeks ago so we might have some feedback on the patients next week

The first patient has been dosed at the initial trial site (University Hospital Southampton NHS Foundation Trust). Synairgen has initiated a further six trial sites which are expected to start dosing in the coming days.

Richard Marsden, CEO of Synairgen, commented: "We are delighted to get this trial underway with the dosing of the first patient. The team has worked tirelessly and intensively with the relevant authorities and collaborators to get to this stage, and we now look forward to recruiting more patients and completing the trial as soon as possible. A successful outcome from this trial in COVID-19 patients would be a very important step towards a major breakthrough in the fight against this coronavirus pandemic."

[wetdream] 17/4/2020 15:40

talk2dubya,

You may be right, but I think the co. has its eye also on securing its P2 development in COPD and asthma sectors, hence the purposes outlined in the Placing.
Fingers crossed, they may well have a ‘winner’ in treating COVID-19, but if not, as finnCap estimate, the share price should hold up around 40-50p as well as giving them some cash in the bank.
Anyway, we now have a new band of investors at 60p-ish who will probably see it to some sort of conclusion.

[imjustdandy] 17/4/2020 15:34

Hopefully news next week -

[imjustdandy] 17/4/2020 15:31

Moving up ever so slightly on RSP

[talk2dubya] 17/4/2020 15:25

KoP - no conflict there. Was rushed IMO. Anyway where we are we are, at least the placing rumours are not going to be an issue on any rise.

I think most of the free carry shares have probably been dumped by now, we might even see this rip higher going in to close.

[kop202] 17/4/2020 15:21

DubyaFinnCap are the NOMAD....they are "advising "

[formula1187] 17/4/2020 15:00

ok no probs, gla another step up bodes well

[bunz3] 17/4/2020 14:59

good discussion on sng at ncyt share board
came over for a quick update
as people watching for rns there

[makendon] 17/4/2020 14:56

Formula1187, re 4082 - already posted on here this morning

makendon - 17 Apr 2020 - 07:51:35 - 3998

[formula1187] 17/4/2020 14:50

First MFT patient recruited to Synairgen COVID-19 research trial



posted on lse

[talk2dubya] 17/4/2020 14:33

Disappointed not to see any TR-1 motivations. Either they are late, the shares have been issued below the notifiable threshold or they have been issued to someone who is outside UK jurisdiction for declaration purposes.

[tialouise] 17/4/2020 14:13

Why do you both with him Dave he'll just bore you to death

[imjustdandy] 17/4/2020 14:09

news can't be far off now. Testing well underway and CEO pretty confident interferon will be a success in COVID-19

[talk2dubya] 17/4/2020 13:57

Wetdream: They should have never have placed that many conditional shares in the first place at such a deep discount.

[wetdream] 17/4/2020 13:51

Imho the conditional placing’s been reasonably well managed so far, given that you’ve got several million shares in the hands of short-termers, happy to sell at c.70% profit currently.
Round number support at 60p close of play today would be a result and provide a good base for any +ve news next week.
Just gotta sit tight.
;-)

[dave444] 17/4/2020 13:35

The conditional placing was 28mThe firm placing was 12m and issued at end of March Read the whole RNS

[talk2dubya] 17/4/2020 13:30

What’s happened to the volume ?

[jonnynixon] 17/4/2020 13:29

From annual meeting rnsThe Conditional Placing and Subscription remain conditional on Admission of the relevant New Ordinary Shares to AIM, which is expected to take place at 8.00 a.m. on Wednesday 15 April 2020.